Susan Burton
About
In The Last Decade
Susan Burton
17 papers receiving 306 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 110
- Endocrine and Autonomic Systems 61
- Physiology 56
- Neurology 44
- Cellular and Molecular Neuroscience 37
Countries citing papers authored by Susan Burton
This map shows the geographic impact of Susan Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Burton more than expected).
Fields of papers citing papers by Susan Burton
This network shows the impact of papers produced by Susan Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Burton. The network helps show where Susan Burton may publish in the future.
Co-authorship network of co-authors of Susan Burton
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Burton. A scholar is included among the top collaborators of Susan Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Burton. Susan Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | Patients and healthcare professionals' experiences of medicine stock-outs and shortages at a community healthcare centre in the Eastern Cape | 4 |
| 4 | 15 | |
| 5 | 2 | |
| 6 | 14 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | An evaluation of energy drinks containing glucose and caffeine, using the TRL Driving Simulator | 1 |
| 10 | A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. | 112 |
| 11 | 8 | |
| 12 | 41 | |
| 13 | 10 | |
| 14 | 41 | |
| 15 | 10 | |
| 16 | 29 | |
| 17 | 7 | |
| 18 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.